Michael Hallek, MD

Rare Disease / Clinical Research

German CLL Study Group, Department I of Internal Medicine University Hospital Cologne

PI on 8 trials

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Myelodysplastic neoplasm with low blasts
B-cell chronic lymphocytic leukemia
Chronic lymphoproliferative disorder of natural killer cells

Clinical trials (8)

NCT02863692
NCT00281918
NCT00309881
NCT00276848
NCT00281892
NCT00262782
NCT00262795
NCT00634881

Verify independently

ClinicalTrials.gov PI search for Michael Hallek, MD

Other specialists for Myelodysplastic neoplasm with low blasts

Peers ranked by clinical-trial PI role, publications, and verification quality.

Ali Al-Mousawi, MD
Rigshospitalet, Denmark
Stine Ulrik Mikkelsen, MD, PhD
Rigshospitalet, Denmark
Harinder Gill, MD, MD
The University of Hong Kong
CA
Kirsten Grønbæk, Prof., MD
Rigshospitalet, Denmark
John Pimanda, Professor
University of New South Wales
Andréa TOMA, MD
Groupe Francophone des Myelodysplasies
François Dreyfus, MD
Groupe Francophone des Myelodysplasies
Elizabeth Griffiths, M.D
Roswell Park Cancer Institute
CA

See all specialists for Myelodysplastic neoplasm with low blasts →

← Back to specialists directory